http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ed0488abd3c0bed1943940b804fda995
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Civelli |
| name | Maurizio Civelli |
| given-name | Maurizio |
| organization-name | Corporate Pre‐clinical R&D Chiesi Farmaceutici S.p.A. Parma Italy Chiesi Farmaceutici S.p.A., Nuovo Centro Ricerche, Largo Belloli 11/a, 43122 Parma, Italy Preclinical R&D, Chiesi Farmaceutici, Parma,Italy From the Cardiology (D.C., A.C., N.C., M.B., G.L., M.C., C.F., C.M.C.) and Laboratory Medicine Units (M.T.S.), Hemato-Oncology Division (F.P., G.M.), Istituto Europeo di Oncologia, University of Milan, Milan, Italy. Head of Global Research & Preclinical Development, Chiesi Farmaceutici S.p.A, Research Center, Largo Belloli 11/a, 43122 Parma, Italy From the Cardiology Unit (D.C., A.C., G.L., N.C., M.C., C.M.C.), Laboratory Medicine Unit (M.T.S.), and Haemato-Oncology Division (G.M.), European Institute of Oncology, I.R.C.C.S., and Centro Cardiologico Monzino (F.V., C.F.), I.R.C.C.S., University of Milan, Milan, Italy. Chemistry Research and Drug Design, ∥Pharmacology and Toxicology, ‡Pharmacokinetics Biochemistry and Metabolism, †Analytics and Early Formulations, #Project Leader Corporate Drug Development, and ⊥Corporate Pre-Clinical R&D Director, Chiesi Farmaceutici S.p.A, Nuovo Centro Ricerche, Largo Belloli 11/a, 43122 Parma, Italy Chiesi Farmaceutici, Parma, Italy NiKem Research, Via Zambeletti 25, 20021 Baranzate, Milan, Italy, Research and Development, Chiesi Farmaceutici S.p.A., Via Palermo 26/A, 43100 Parma, Italy, and Preclinical Research and Development, Laboratorios SALVAT, Gall 30-36, 08950-Esplugues de Llobregat, Barcelona, Spain Chiesi Farmaceutici S.p.A., Centro Ricerche, Largo Belloli 11/a, 43122 Parma, Italy Nuovo Centro Ricerche, Chiesi Farmaceutici S.p.A., Largo Belloli 11/a, 43122 Parma, Italy Preclinical Research and Development, Chiesi Farmaceutici S.p.A., Parma, Italy; and From the European Institute of Oncology and Centro Cardiologico Monzino, Istituto Di Ricovero e Cura a Carattere Scientifico, Milan, Italy. Cardiology Unit, Chiesi Farmaceutici S.p.A Parma Italy Chiesi Farmaceutici S.p.A, Centro Ricerche, Largo Belloli 11/a, 43122 Parma, Italy Department of Cardiology European Institute of Oncology Milan Italy From European Institute of Oncology, Milan, Italy (D.C., A.C., G.B., I.T., C.A.M., M.C., G.L., N.C., G.C., C.M.C.); and Centro Cardiologico Monzino (I.R.C.C.S.), Milan, Italy (F.V., C.F.). Department of Pharmaceutical ChemistryUniversity of Ferrara Ferrara Italy Cardiology Division, European Institute of Oncology, I.R.C.C.S., Milan, Italy Corporate Pre-clinical Research and Development, Chiesi Farmaceutici, Parma, Italy Corporate Pre‐Clinical R&D Chiesi Farmaceutici S.p.A. Parma Italy From the Cardiology Unit (D.C., A.C., G.L., N.C., M.C., C.M.C.), Laboratory Medicine Unit (M.T.S., M.S.), and Division of Thoracic Surgery (G.V., L.S.), European Institute of Oncology, IRCCS, and Centro Cardiologico Monzino (F.V., C.F.), IRCCS, University of Milan, Milan, Italy. |
Incoming Links
Total number of triples: 94.